Following the addition of 15 employees and 6 new attorneys to take a market-leading position in 2018, Nelson Hardiman announced a new management structure today, including new partners.
Stacie Neroni is joining Harry Nelson as co-managing partner of the firm. Neroni joined Nelson Hardiman in early 2018 with Hope Levy-Biehl, where both had served in firm management roles. “It was evident from day one that Stacie is a natural leader,” said Nelson. “She had an immediate, significant impact in improving our internal operations. We felt it was an important step in our continued growth to formalize her management role.”
“When Hope and I made our decision to join Nelson Hardiman,” said Neroni, “one of the factors we found exciting was the opportunity to utilize our experiences and insights to influence and shape a burgeoning and growing health law boutique into something more aligned with our vision and goals for a firm where we could feel at home. We have been overwhelmingly surprised and gratified by how everyone at Nelson Hardiman, including management, attorneys and staff, have embraced us and our input. Personally, I am especially humbled by the trust and respect shown by Harry and everyone at the firm in offering me this opportunity.”
The shift continues Nelson Hardiman’s internal reorganization earlier this year, in which partners Hope Levy-Biehl and Rob Fuller became co-chairs of the firm’s Regulatory/Transactional Practice Group and John Mills and Zach Rothenberg became co-chairs of the firm’s Litigation Practice Group. “One of the lessons we’ve learned from other law firms has been the need to cultivate leadership succession within our organizational culture,” said Nelson. “Our focus continues to be on diversifying our leadership and creating a collaborative structure with more opportunities for more of our team to contribute to our shared vision.”
In a separate management change, former Executive Director Gina Martin rejoined the firm. Martin had served as the firm’s administrator from 2013 through 2017, and had joined Hahn and Hahn, LLP in early 2018. “Returning to Nelson Hardiman, felt like coming home,” said Martin. “I look forward to helping contribute to the ongoing growth and development of the firm. ” Partner Mark Hardiman added: “Gina Martin played an integral role in Nelson Hardiman’s growth. It says something good about what’s happening here that she decided to return to play a leadership role.”
Nelson Hardiman also announced that Larry Gill and Jonathan Radke had become partners in the firm. Gill, who previously managed ALJ Capital, a hedge fund, as well as Adaptive Health Capital, brings over 25 years of experience working closely with investors and lenders. “As we continued to grow our practice representing healthcare and life sciences private equity and other investors, as well as lenders, Larry Gill’s leadership has been invaluable,” said partner Rob Fuller. Gill signaled excitement about his elevation: “You don’t run into a professional firm with the quality of people and level of expertise and skill of a Nelson Hardiman every day. I am humbled to bring my experience in corporate finance, insolvency and private investing into this amazing firm, and I look forward to many exciting years of dynamic change in the health care and life science industries.”
New partner Jonathan Radke plays a key role in Nelson Hardiman’s litigation practice group, with particular expertise in defending healthcare providers in the clinical laboratory, behavioral health, and ambulance industries against civil false claims allegations involving government programs and commercial plans. “Jonathan has developed a well-deserved reputation as a go-to attorney when clients are facing whistleblower fraud allegations, especially involving commercial plan claims, a rapidly developing area that many providers are not familiar with,” said co-chair John Mills. Radke stated that he was also excited about his new status: “Nelson Hardiman is a dynamic and innovative firm that prides itself on innovative, aggressive and efficient representation of its health care provider clients in litigation and I am honored to join the leadership of a firm with such a deep bench of legal talent.”
About Nelson Hardiman
Nelson Hardiman LLP is the largest healthcare and life sciences firm in Los Angeles, serving healthcare providers, investors, and organizations that need a hard-to-find level of quality advice on the most sensitive industry issues. The firm’s litigation practice specializes in defending fraud and abuse and whistleblower actions, government investigations, reimbursement disputes, and other complex business disputes. Nelson Hardiman’s transactional group handles healthcare organization acquisitions, sales, investment, and financings, and Nelson Hardiman’s regulatory team advises on compliance with licensing, operational, and reimbursement issues across the full continuum of healthcare industry sectors, with expertise on Medicare and Medicaid requirements, privacy and data security, FDA, and many more matters. The firm has earned a singular position reputation nationally for its leadership in addressing issues in behavioral health. More information about the firm is available at www.nelsonhardiman.com or at 310.203.2800.